Additionally, we noted the downregulation of SCD, coupled with the upregulation of PTGS1 and PTGSE, in tumor samples from some HER2‐positive breast cancer patients exhibiting secondary trastuzumab resistance compared to trastuzumab‐sensitive patients. The gene discussed is PTGS1; the disease is breast carcinoma.